BRIEF published on 02/26/2026 at 15:35, 1 month 26 days ago Ottobock Invests in Blue Arbor Technologies for Advanced Prosthesis Control MedTech Ottobock Investment Prosthesis Control RESTORE Technology Blue Arbor
PRESS RELEASE published on 02/26/2026 at 15:30, 1 month 26 days ago Ottobock invests in future technology from Blue Arbor Technologies, Inc. Ottobock strengthens innovation with a $5 million investment in Blue Arbor Technologies, Inc.'s RESTORE implant technology for intuitive prosthesis control Investment Ottobock Prosthesis Control RESTORE Technology Blue Arbor Technologies
BRIEF published on 02/17/2026 at 07:34, 2 months 8 days ago Ottobock enregistre des résultats records et une forte croissance en 2025 Stratégie De Croissance Expansion Du Marché Prévisions Pour 2026 Résultats Financiers D'Ottobock Bionique Humaine
BRIEF published on 02/17/2026 at 07:34, 2 months 8 days ago Ottobock Achieves Record Results with Strong Growth in 2025 Growth Strategy Market Expansion Human Bionics 2026 Forecast Ottobock Financial Results
PRESS RELEASE published on 02/17/2026 at 07:29, 2 months 8 days ago Record results for Ottobock: Double-digit growth, strong profit growth, positive outlook Ottobock SE & Co. KGaA achieved record results in 2025 with double-digit growth in core revenue and strong profit growth, maintaining a positive outlook for 2026 Outlook Double-digit Growth Record Results Profit Growth Ottobock
BRIEF published on 11/13/2025 at 07:34, 5 months 12 days ago Ottobock prévoit une forte croissance de son chiffre d'affaires et de sa rentabilité sur les 9 premiers mois de l'année 2025. Croissance Financière Marge D'EBITDA Ottobock Prévisions Pour 2025 Lancement De Produits
BRIEF published on 11/13/2025 at 07:34, 5 months 12 days ago Ottobock Sees Strong Growth in Revenue and Profitability in 9M 2025 EBITDA Margin Product Launches Financial Growth Ottobock 2025 Forecast
PRESS RELEASE published on 11/13/2025 at 07:29, 5 months 12 days ago Ottobock generates strong revenue growth and increases profitability in 9M 2025 Ottobock achieves strong revenue growth and increased profitability in the first nine months of 2025. Key drivers include new product launches and strategic investments Revenue Growth Profitability MedTech Ottobock 9M 2025
BRIEF published on 10/24/2025 at 07:49, 6 months 1 day ago Ottobock renforce son investissement dans la société de neurotechnologie ONWARD® Medical Ottobock ONWARD Medical Système ARC-EX Lésion De La Moelle Épinière Investissement Dans NeuroTech
BRIEF published on 10/24/2025 at 07:49, 6 months 1 day ago Ottobock Strengthens Investment in NeuroTech Company ONWARD® Medical Ottobock ONWARD Medical ARC-EX System Spinal Cord Injury NeuroTech Investment
Published on 04/25/2026 at 03:10, 9 hours 38 minutes ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 14 hours 43 minutes ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:05, 14 hours 43 minutes ago Critical Elements Pleure la perte de son administrateur Marc Simpson
Published on 04/24/2026 at 22:00, 14 hours 48 minutes ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 21 hours 48 minutes ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 22:43, 14 hours 5 minutes ago EQS-Adhoc: Marley Spoon Group SE: Closing of the financing transaction in connection with the financial restructuring of its German subsidiary Marley Spoon SE with increased financing amou
Published on 04/24/2026 at 22:05, 14 hours 43 minutes ago Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
Published on 04/24/2026 at 18:30, 18 hours 18 minutes ago EUROPLASMA: Tirage de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2M€
Published on 04/24/2026 at 18:12, 18 hours 36 minutes ago EQS-Adhoc: clearvise AG reviews dividend proposal in line with its dividend strategy and postpones Annual General Meeting
Published on 04/24/2026 at 18:07, 18 hours 41 minutes ago DEAG sets new records for revenue and earnings in financial year 2025 – excellently positioned for long-term growth
Published on 04/25/2026 at 07:00, 5 hours 48 minutes ago DLSI - Chiffre d'affaires 1er trimestre 2026
Published on 04/24/2026 at 18:00, 18 hours 48 minutes ago SMTPC - Communiqué sur la mise à disposition du Rapport annuel 2025
Published on 04/24/2026 at 17:45, 19 hours 3 minutes ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
